The Lordina Foundation, led by First Lady Mrs Lordina Dramani Mahama, has built, fully equipped and handed over an ...
In the Phase 3 AFFIRM study in adults with moderately to severely active Crohn's disease, risankizumab (SKYRIZI®) achieved superiority for the co-primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results